AMY VOS: Open Payments
NPI 1700269453 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 53 payments from 12 companies in 2025. Trend: 2023 $995 · 2024 $846 · 2025 $1,333
Food & beverage: $1,325Education: $8
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $508 |
| GENZYME CORPORATION | 15 | $351 |
| Genentech USA, Inc. | 4 | $114 |
| CSL Behring | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| Ionis Pharmaceuticals, Inc. | 2 | $41 |
| BioCryst US Sales Co., LLC | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xolair, Haegarda, BREZTRI, ORLADEYO, NUCALA.
Industry payments across CO — which companies pay providers there.
